Results 141 to 150 of about 1,911,183 (308)

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

open access: yesMolecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park   +6 more
wiley   +1 more source

May Oversight Report

open access: yes, 2010
May report of the U.S. Congressional Oversight Panel describing their activities and findings regarding the financial assistance and extension of credit to small businesses through the U.S. Treasury's Troubled Asset Relief Program (TARP)
United States. Congressional Oversight Panel.
core  

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

open access: yesMolecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang   +9 more
wiley   +1 more source

December Oversight Report

open access: yes, 2009
December report of the U.S. Congressional Oversight Panel describing their activities and findings regarding the U.S. Treasury's Troubled Asset Relief Program (TARP), including sections on the background and evolution of TARP, and an analysis of its ...
United States. Congressional Oversight Panel.
core  

CEACAM1 participation in breast cancer progression

open access: yesMolecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin   +3 more
wiley   +1 more source

October Oversight Report

open access: yes, 2010
October report of the U.S. Congressional Oversight Panel describing their activities and findings regarding the use of private contractors in the implementation of the U.S. Treasury's Troubled Asset Relief Program (TARP)
United States. Congressional Oversight Panel.
core  

Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer

open access: yesMolecular Oncology, EarlyView.
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche   +10 more
wiley   +1 more source

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

open access: yesMolecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi   +6 more
wiley   +1 more source

Predicting recurrence of depression using lifelog data: an explanatory feasibility study with a panel VAR approach. [PDF]

open access: yesBMC Psychiatry, 2019
Kumagai N   +8 more
europepmc   +1 more source

July Oversight Report

open access: yes, 2008
July report of the U.S. Congressional Oversight Panel describing their activities and findings regarding the repayment of financial assistance that banks received from the U.S. Treasury through the Troubled Asset Relief Program (TARP)
United States. Congressional Oversight Panel.
core  

Home - About - Disclaimer - Privacy